CheckMan Stock Market Overview
Trending Stocks
Red List
In Today's Headlines

Tiziana Life Sciences Ltd (NASDAQ:TLSA) announced that it has completed patient enrollment in its Phase 2a clinical trial evaluating intranasal foralumab in patients with non-active secondary progressive multiple sclerosis (na-SPMS), marking a key milestone for the company's lead drug candidate. The randomized, double-blind, placebo-controlled study, known as INFORM-MS (NCT06292923), is assessing the safety and potential efficacy of intranasal foralumab, a fully human anti-CD3 monoclonal antibody designed to modulate immune activity and reduce neuroinflammation.

With the market chasing AI hyperscalers, income investors are getting an unusual gift: high-quality, asset-backed REITs trading in the single digits.

Quadient Q1 2026 revenue: Strong bookings and usage growth accelerating Digital platform adoption FY 2026 guidance confirmed

Retail scale still matters. But Walmart's first quarter of fiscal year 2027 made clear the company's next phase of growth runs through something harder to copy than store count: how customers move between stores, delivery, digital channels and membership ecosystems.

NVIDIA (NASDAQ:NVDA | NVDA Price Prediction) just delivered one of the most consequential quarters in semiconductor history, and the stock is responding.
Vancouver, British Columbia--(Newsfile Corp. - May 21, 2026) - Iconic Minerals Ltd. (TSXV: ICM) (OTCQB: ICMFF) (FSE: YQG) (the "Company" or "Iconic") announces that drilling is now underway at its New Pass Gold Property ("New Pass" or the "Property") in Churchill County, Nevada.

SoFi Technologies (NASDAQ:SOFI | SOFI Price Prediction) minted its own stablecoin on a public blockchain and signed Mastercard to settle it globally.

GOOGL, MSFT, ANET and CIEN are some indispensable cloud computing stocks to any investment portfolio.

Atara stock soars 82% as the FDA outlines a regulatory pathway for its lead product candidate, tab-cel, reviving hopes for potential U.S. approval, after two prior CRLs.

DE beats Q2 earnings and sales estimates as Small Ag & Turf, and Construction & Forestry drive revenue growth despite weaker ag demand.
